COVISHIELD

Approval Id: 1cb99c48b0025add
Drug Approval Canada Name: COVISHIELD
Product Name: COVISHIELD
Status: Authorization By Interim Order Expired
Status Date: 2021-09-16
Original Market Date: 2021-03-03
Din: 02512947
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intramuscular
Schedule: COVID-19 - IO - Authorization , Schedule D
Atc Original: J07BN02 COVID-19, VIRAL VECTOR, NON-REPLICATING
Atc Name: j 07 bn 02
Aig Number: 0162722001
Company Name: Verity Pharmaceuticals Inc.
Company Address: 2560 Matheson Blvd. E., Suite 220, Mississauga, Ontario, Canada, L4W 4Y9
Company Detail Path: /organization/verity-pharmaceuticals-inc

CHADOX1-S [RECOMBINANT]

50000000000 VP / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

1cb99c48b0025add

Type

Standard